Literature DB >> 12419437

Reirradiation of nasopharyngeal carcinoma with intracavitary mold brachytherapy: an effective means of local salvage.

Stephen C K Law1, Wing-Kit Lam, Man-Fai Ng, Siu-Kie Au, Wing-Tai Mak, Wai-Hon Lau.   

Abstract

PURPOSE: To assess the role of intracavitary mold brachytherapy in salvaging local failure of nasopharyngeal carcinoma (NPC). METHODS AND MATERIALS: The outcomes of 118 consecutive NPC patients with local failure treated with mold brachytherapy between 1989 and 1996 were retrospectively reviewed. Eleven patients received additional external radiotherapy.
RESULTS: All molds were tailor-made, and the whole procedure was performed under local anesthesia. Pharyngeal recess dissection was routinely performed to allow direct contact of the radioactive source with the pharyngeal recess, a common site of local failure. Initially, the molds were preloaded with 192Ir wires, but since 1992, the sources have been manually afterloaded; the mold has also been redesigned for better conformity, ease of insertion, and radiation safety. Using brachytherapy alone, 50-55 Gy was given for recurrence in 4-7 days; for persistence, 40 Gy was administered. The overall complete remission rate was 97%. The rates of 5-year local control, relapse-free survival, disease-specific survival, overall survival, and major complication were 85%, 68.3%, 74.8%, 61.3%, and 46.9%, respectively. Major complications included nasopharyngeal necrosis with headache, necrosis of cervical vertebrae with atlantoaxial instability, temporal lobe necrosis, and palsy of the cranial nerves. The afterloaded mold was as effective as the preloaded version, but with fewer complications.
CONCLUSIONS: Intracavitary mold brachytherapy was effective in salvaging NPC with early-stage local persistence or first recurrence.

Entities:  

Mesh:

Year:  2002        PMID: 12419437     DOI: 10.1016/s0360-3016(02)03009-2

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  12 in total

1.  Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Authors:  Victor H F Lee; Dora L W Kwong; To-Wai Leung; Sherry C Y Ng; Ka-On Lam; Chi-Chung Tong; Chun-Kin Sze
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-10-13       Impact factor: 2.503

2.  Current management strategy of nasopharyngeal carcinoma.

Authors:  William I Wei; Dora L W Kwong
Journal:  Clin Exp Otorhinolaryngol       Date:  2010-03-30       Impact factor: 3.372

3.  Intensity modulated or fractionated stereotactic reirradiation in patients with recurrent nasopharyngeal cancer.

Authors:  Falk Roeder; Felix Zwicker; Ladan Saleh-Ebrahimi; Carmen Timke; Christian Thieke; Marc Bischof; Juergen Debus; Peter E Huber
Journal:  Radiat Oncol       Date:  2011-03-01       Impact factor: 3.481

Review 4.  Reirradiation of head and neck cancer focusing on hypofractionated stereotactic body radiation therapy.

Authors:  Hideya Yamazaki; Naohiro Kodani; Mikio Ogita; Kengo Sato; Kengo Himei
Journal:  Radiat Oncol       Date:  2011-08-21       Impact factor: 3.481

5.  Prognostic model for survival of local recurrent nasopharyngeal carcinoma with intensity-modulated radiotherapy.

Authors:  Y-M Tian; Y-H Tian; L Zeng; S Liu; Y Guan; T-X Lu; F Han
Journal:  Br J Cancer       Date:  2013-12-12       Impact factor: 7.640

6.  Advantages of intensity modulated radiotherapy in recurrent T1-2 nasopharyngeal carcinoma: a retrospective study.

Authors:  Sufang Qiu; Jun Lu; Wei Zheng; Luying Xu; Shaojun Lin; Chaobin Huang; Yuanji Xu; Lingling Huang; Jianji Pan
Journal:  BMC Cancer       Date:  2014-11-03       Impact factor: 4.430

7.  Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia.

Authors:  Ahmed Marzouk Maklad; Yasser Bayoumi; Mohamed Abdalazez Senosy Hassan; AbuSaleh A Elawadi; Hussain AlHussain; Ashraf Elyamany; Saleh F Aldhahri; Khalid Hussain Al-Qahtani; Mubarak AlQahtani; Mutahir A Tunio
Journal:  Onco Targets Ther       Date:  2016-10-25       Impact factor: 4.147

Review 8.  Photodynamic therapy in the therapy for recurrent/persistent nasopharyngeal cancer.

Authors:  Maarten A M Wildeman; Heike J Nyst; Baris Karakullukcu; Bing I Tan
Journal:  Head Neck Oncol       Date:  2009-12-17

9.  Refractory lympho-epithelial carcinoma of the nasopharynx: a case report illustrating a protracted clinical course.

Authors:  Frederick Y Wu; Eddy S Yang; Christopher D Willey; Kim Ely; Gaelyn Garrett; Anthony J Cmelak
Journal:  Head Neck Oncol       Date:  2009-06-15

Review 10.  Current treatment options for local residual nasopharyngeal carcinoma.

Authors:  S D Stoker; J N A van Diessen; J P de Boer; B Karakullukcu; C R Leemans; I B Tan
Journal:  Curr Treat Options Oncol       Date:  2013-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.